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Matthew R. Kutcher*

The Chemical Castration of Recidivist Sex
Offenders in Canada: A Matter of Faith

Chemical castration refers to the use of medication to reduce male testosterone
to pre-pubertal levels. Since the mid-20th century reports have detailed this
practice in attempts to control pathological sexual behaviour. In 2006, the
Canadian Federal Court of Appeal ruled it constitutional for the National Parole
Board to require that recidivist sex offenders, if found to be long-term offenders,
be chemically castrated under their conditions of release. This paper examines
the chemical castration of recidivist sex offenders in Canada through a review
of long-term offender hearings reported between 1997 and 2009. The practice
is analyzed from ethical, medical and legal perspectives. It is concluded that
chemical castration of sex offenders is ethically problematic, that evidence for
its effectiveness in preventing recidivism is limited and of poor quality and that
judges should avoid excessive reliance on chemical castration when deciding to
grant conditional release to recidivist sex offenders.
On appelle castration chimique l'utilisation de mddicaments pour rdduire le
niveau de testostdrone chez les hommes & des niveaux pr6pubbres. Depuis
le milieu du XXe sidcle, des rapports ont d~crit en ddtail cette pratique dont
l'objectif est de contraler les comportements sexuels pathologiques. En 2006,
la Cour f6d6rale d'appel a ddclard que la Commission nationale des lib6rations
conditionnelles peut constitutionnellement imposer, comme condition de mise en
libert6 des recidivistes sexuels d6clards <<d6linquantssexuels &contr6ler>>, qu'ils
soient castres chimiquement. L'auteur, pour examiner la castration chimique de
rdcidivistes sexuels au Canada, a pass6 en revue les audiences des d6linquants
sexuels ayant dtd ddclards J contrdler rapportdes entre 1997 et 2009. La pratique
est analysde de perspectives 6thique, mbdicale et juridique. 11conclut que la
castration chimique des d6linquants sexuels estproblmatique sur le plan 6thique,
que les preuves de son efficacit6 pour empdcher les r~cidives sont limitdes et
de pidtre qualit6 et que les juges devraient 6viter d'accorder trop dimportance
6 la castration chimique lorsqu'ils ddcident d'accorder la mise en libert6 sous
condition aux ddlinquants sexuels qui ont rdcidiv6.
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Introduction
Every human being of adult years and sound mind has a right to determine
what shall be done with his own body.'
-Justice Cardozo (1914)
And if your eye causes you to sin, pluck it out. [Mark 9:47]
In Canada, forced medical treatment under the law is subject to strict
controls because it invites egregious violations of fundamental human
rights.2 Law in this area is rooted in long-standing common law concepts'

1. Schloendorff v Society ofNew York Hospital,[1914] 211 NY 125 at 5, 105 NE 92.
2. See Patricia Peppin, "Informed Consent" in Jocelyn Downie, Timothy Caulfield & Colleen
Flood, eds, CanadianHealth Law and Policy (Ontario: LexisNexis Canada, 2007) at 189.
3. See Malette v Shulman (1990), 72 OR (2d) 417 at para 17, 67 DLR (4th) 321. See also Allen M
Linden, Lewis N Klar & Bruce Feldthusen, eds, Canadian Tort Law, 12th ed (Ontario: LexisNexis
Canada, 2004) at 35; Peppin, supranote 2 at 190.

The Chemical Castration of Recidivist Sex Offenders in Canada

195

but is now also grounded in the Canadian Constitution through the Charter
of Rights and Freedoms.4
Canadian legal controls on compulsory medical treatment (regardless
of their origin in statute, the common law or the Charter)attempt to balance
individual rights with competing social interests.' The laws tend to limit
the contexts in which medical treatments can be made legally compulsory
by mandating procedural protections to prevent possible abuse of state
power. Process-based protections typically introduce legal requirements
for independent oversight and review of compulsory treatment orders,6
together with provisions that enable those subject to compulsory treatment
to contest the legal basis on which their treatment has been authorized.'
In Canada, legal issues surrounding compulsory medical treatment arise
most often in the context of public health and mental health.
This paper discusses a third area in which Canadian law authorizes
compulsory medical treatment: the legally mandated use of medications
to chemically castrate recidivist sex offenders.' This area has yet to
receive much attention from Canadian legal scholars,' but its discussion

4.
See Fleming v Reid (1991), 4 OR (3d) 74 at para 39, 82 DLR (4th) 298 (CA), Robins JA ("The
common law right to bodily integrity and personal autonomy is so entrenched in the traditions of our
law as to be ranked as fundamental and deserving of the highest order of protection. This right forms
an essential part of an individual's security of the person and must be included in the liberty interests
protected by s 7 [of the Charter]. Indeed, in my view, the common law right to determine what shall
be done with one's own body and the constitutional right to security of the person, both of which are
founded on the belief in the dignity and autonomy of each individual, can be treated as coextensive.")
But see Deacon v Canada (Attorney General), 2006 FCA 265 at para 73, [2007] 2 FCR 607, Linden
JA ("It is thus apparent that Fleming v. Reid was dealing with a particular fact situation and did not
suggest that an unqualified or absolute right to refuse medication in all situations is a principle of
fundamental justice under section 7.").
5.
See e.g. Peter J Carver, "Mental Health Law in Canada" in Jocelyn Downie, Timothy Caulfield
& Colleen Flood, eds, Canadian Health Law and Policy (Ontario: LexisNexis Canada, 2007) at 405.
See also Nola M Ries, "Legal Foundations of Public Health in Canada" in Tracey M Bailey, Timothy
Caulfield & Nola Ries, eds, Public Health Law & Policy in Canada (Ontario: LexisNexis Canada,
2005) at 9.
6.
See e.g. Involuntary Psychiatric Treatment Act, SNS 2005, c 42, s 26. Also see Health Protection
Act, SNS 2004, c 4, s 47.
Ibid.
7.
8.
See generally Peer Briken & Martin P Kafka, "Pharmacological treatments for paraphilic patients
and sexual offenders" (2007) 20 Curr Opin Psych 609.
9.
This issue has however received attention in the US legal literature. See e.g. Kris W Druhm,
"A Welcome Return to Draconia: California Penal Law 645, The Castration of Sex Offenders and
the Constitution" (1997) 61 Alb L Rev 285; Raymond A Lombardo, "California's Unconstitutional
Punishment for Heinous Crimes: Chemical Castration of Sex Offenders" (1997) 65 Fordham L Rev
2611; Matthew V Daley, "A Flawed Solution to the Sex Offender Situation in the United States: The
Legality of Chemical Castration for Sex Offenders" (2008) 5 Ind Health L Rev 87.
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is important because of the likelihood that severe harm will result should
the law go the least bit astray.'0
The purpose of this paper is to identify and discuss medico-legal and
ethical issues that emerge from the legally mandated use of medications,
to chemically castrate recidivist sex offenders in Canada. The issues are
presented in the context of a review of reported dangerous and long-term
offender hearings (since 1997)" that included judicial evaluation of the
utility of chemical castration for preventing recidivism in chronically
offending pedophiles.12 This examination offers a contextually embedded
opportunity to explore legal and ethical issues surrounding compulsory
chemical castration.
The first section of this paper introduces chemical castration by
explaining what it is and how it is achieved, and by exploring the history
and science behind its use as a treatment for sexual deviancy. The second
section describes the legal setting and processes through which the
Canadian legal system encounters and engages with the idea of mandated
chemical castration. This section describes the operation of Part XXIV of
the Criminal Code (Dangerous Offenders) to explain how and why the
contemplation of chemical castration takes place in Canadian courts. A
discussion of the constitutionality of imposing forced medical treatment
under long-term supervision orders is also included. The third section
discusses the state of the medical evidence supporting the efficacy of
chemical castration as a method for preventing recidivism among sex
offenders. The fourth section discusses ethical issues flowing from the
use of chemical castration in Canada and identifies a number of troubling
issues that arise in this context. The final section summarizes the paper and
makes recommendations regarding future use of chemical castration.

10. Here, the term'harm'is used in a broad sense, referring to both physical and mental/psychological
harms.
11. The choice of 1997 follows from the fact that the long-term offender regime did not come into
force until August of 1997 with the proclamation of An Act to amend the Criminal Code (high-risk
offenders), SC 1997, c 17.
12. The cases where long-term offender status was granted are: R v JSM 2003 BCSC 1813, [2003]
BCJ no 2991; R v Stoney, 2004 ABPC 3, 32 Alta LR (4th) 282; R v Lalo, 2004 NSSC 154, 225 NSR
(2d) 344; R v SS, [2005] OTC 267, [2005] OJ no 1391 (Sup Ct J); R v Mumford, [2007] OJ no 4267, 75
WCB (2d) 784 (Sup Ct J); R v Smith, [2008] OJ no 2196, 77 WCB (2d) 654 (Sup Ct J); and R v RTM,
2009 ABQB 594, [2009] AJ no 1145. The cases where a dangerous offender designation was given
are: R v Roby, 2000 CarswellOnt 6281 (Sup Ct J); Rv AES, [2004] OJ no 5192 (Sup Ct J); R v RM
(2005), 68 WCB (2d) 78, [2005] OJ no 4977 (Sup Ct J); R v JMH (2005), 67 WCB (2d) 351, [2005]
OJ no 4169 (Sup Ct J); R v WGL (2006), 71 WCB (2d) 125, [2006] OJ no 4029 (Sup Ct J); R v L(W),
2006 CarswellOnt 6141 (Sup Ct J); R v DGB, 2008 ABQB 302, 77 WCB (2d) 725; and R v Maxwell,
2009 ONCJ 362, [2009] OJ no 3328.
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I. Chemical castration
Chemical castration is the practice of administering to post-pubertal males
medication that reduces their circulating testosterone to pre-pubertal
levels.' It achieves, in effect, reversible drug-induced biochemical
mimicry of surgical castration.14
In defining chemical castration it is important to note that although
the term is popularly used in lay publications" and occasionally in
specialist publications,' 6 it often gives way to more specific, albeit less
evocative, terminology in specialist literature. For example, in the medical
literature reference is made to the use of 'antiandrogen medication',
'hormonal medication', 'sex drive reducing medication' and 'antilibidinal
medications' in place of the term chemical castration." However, the term
chemical castration is still used in the Canadian judicial context'" and
therefore in this paper.
Several pharmacological agents can be used to achieve chemical
castration. These include medroxyprogesterone acetate (MPA),
cyproterone acetate (CPA), and luteinizing-hormone-releasing hormone
(LHRH) agonists.
MPA is a progestational steroid that reduces levels of testosterone 5a
reductase in the liver,'9 which increases testosterone clearance and leads
to decreased testosterone levels in serum and tissues.20 In addition, MPA
decreases the secretion of gonadotropins via a mechanism that remains
to be elucidated. MPA is perhaps most commonly known as the active
ingredient in the long-acting reversible hormonal contraceptive birth
control drug sold under the name Depo-Provera.

13. Briken & Kafka, supra note 8 at 610.
14. The drugs used to achieve chemical castration effectively lower a man's testosterone level to an
extent similar to that achieved via surgical castration. This treatment is apparently reversible because
testosterone levels can often return to normal in the weeks after drug treatment has stopped.
15. See e.g. Canwest News Service, "Chemical castration of pedophile upheld by federal court"
CanWest Media Publications Inc (9 August 2006), online: <http://www.canada.com/topics/news/
national/story.htmlid=3bea636f-3999-4b90-9997-6b5436f608ec&k=72044>.
16. See e.g. Editors, "Chemical castration for paedophiles approved" (1996) 313 BMJ 707.
17. See e.g. Fred S Berlin, "Commentary: Risk/Benefit Ratio of Androgen Deprivation Treatment
for Sex Offenders" (2009) 37 JAAPL 59.
18. See e.g. Steel v Mountain Institution (1989), 72 CR (3d) 58 at 110, 8 WCB (2d) 7 (BCSC); R v
Stuckless (1998),41 OR (3d) 103 at 123, 17 CR (5th) 330 (CA); Lalo, supranote 12 atpara 74; WGL,
supranote 12 at para 102; and Smith, supra note 12 at para 89.
19. Testosterone 5ac reductase is the enzyme that converts testosterone in vivo to its biologically
active metabolite.
20. See generally John MW Bradford, "Organic Treatments for the Male Sexual Offender" (1985) 3
Behav Sci Law 355; Victoria L Codispoti, "Pharmacology of Sexually Compulsive Behavior" (2008)
31 Psychiatr Clin N Am 671; and David RP Guay, "Drug Treatment of Paraphilic and Nonparaphilic
Sexual Disorders" (2009) 31 Clin Ther 1.
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MPA is clinically indicated for use in the treatment of endometrial
carcinoma or renal carcinoma; secondary amenorrhea or abnormal uterine
bleeding due to hormonal imbalance; reduction of endometrial hyperplasia
in non-hysterectomized postmenopausal women receiving conjugated
estrogens; prevention of pregnancy; and management of endometriosisassociated pain.2 1 MPA is not approved by Health Canada for the treatment
of sexual disorders.
CPA is a steroid that has both antigonadotrophic and antiandrogenic
properties. CPA acts as an antigonadotrophic agent by inhibiting the
secretion of luteinizing-hormone, which leads to decreased production of
testosterone in the testes.. CPA is considered a true antiandrogen because
it competitively inhibits the binding of dihydrotesterone (the biologically
active metabolite of testosterone) at androgen receptors. 2 2 Therefore,
CPA both reduces the production of testosterone and blocks its biological
effects.
Approved clinical indications for CPA include use in the palliative
treatment of patients with advanced prostatic carcinoma (under the brand
name Androcur) and also in women requiring a dual-purpose acne therapy/
oral contraceptive (under the brand names CyEstram-35 and DIANE@35). CPA is not approved by Health Canada for the treatment of sexual
disorders.
LHRH agonists cause a paradoxical reduction in circulating
testosterone by overstimulating the hypothalamus. LHRH secretion
stimulates cells in the anterior pituitary to release the gonadotrophicreleasing hormones, follicle-stimulating hormone (FSH) and luteinizing
hormone (LH). 23 Although these hormones typically work to stimulate
the production and release of testosterone, continuous application of longacting LHRH agonists instead causes the pituitary-gonadal axis to become
suppressed. As a result, the secretion of FSH and LH becomes inhibited
and testosterone drops to castration levels. 24
As a class, LHRH agonists (also known as gonadotropin-releasing
hormone analogues) are clinically indicated in the management and
treatment of endometriosis, central precocious puberty in children, and

21. Medroxyprogesterone, Drug Monographs (Access medicine, The McGraw-Hill Companies).
22. Supra note 20.
23. Supra note 20. See also Peer Briken, Andreas Hill & Wolfgang Berner, "Pharmacotherapy of
Paraphilias with Long-Acting Agonists of Luteinizing Hormone-Releasing Hormone: A Systematic
Review" (2003) 64 J Clin Psychiatry 890.
24. Ibid.
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advanced prostatic carcinoma.2 5 LHRH agonists are not approved by
Health Canada for the treatment of sexual disorders.
II. Chemicalcastration:an historicalperspective
It has been suggested that the contemporary use of antiandrogenic
medications in the treatment of paraphilias2 6 evolved from ancient
practices employing surgical castration as a means of social control;27
however, the practice is now promulgated largely under the banner
of modem neurobiology and neuropharmacology.2 8 Two evolutionary
movements characterize the recent history of castration as a treatment
for sex offenders. The first was the move away from viewing castration
as punishment toward the conceptualization of castration as a therapy,
which took place during the late 19th and early 20th centuries. The second
was a move away from the surgical removal of the testes towards using
chemicals to reduce testosterone levels (which took place during the first
half of the 20th century).
The surgical castration of sexual offenders has been used as a
punishment since ancient times, its prescription flowing clearly from
the biblical dictum of 'an eye for an eye'. 29 In North America, the use
of surgical castration as a putatively therapeutic method for preventing
recidivism in sex offenders stems from the work of Dr. Harry Sharp.30 Dr.
Sharp was an Indiana physician who, during the late 1890s, promoted the
'castration as therapy'model after surgically castrating 176 male prisoners
in an attempt to decrease their sexual urges.31 Although the practice of
compulsory surgical castration of sex offenders under the law continues
in at least one European jurisdiction3 2 and remains an option (i.e., as a
voluntary alternative to chemical castration) for recidivist sex offenders
25. Gonadotrophin-Releasing Hormone Agonists, Drug Monographs (Access medicine, The
McGraw-Hill Companies).
26. Paraphilia is a clinical psychiatric term used to describe sexual arousal to objects or situations
that are not considered a part of normal behaviour, e.g. animals or young children. See Hy Bloom
& Richard D Schneider, Mental Disorder and the Law: A Primerfor Legal and Mental Health
Professionals(Toronto, Ontario: Irwin Law, 2006) at 157-60.
27. Charles L Scott & Trent Holmberg, "Castration of Sex Offenders: Prisoner's Rights Versus
Public Safety" (2003) 31 JAAPL 502.
28. John MW Bradford, "The Neurobiology, Neuropharmacology, and Pharmacological Treatment
of Paraphilias and Compulsive Sexual Behaviour" (2001) 46 Can J Psychiatry 26.
29. Robert D Miller, "Forced Administration of Sex-Drive Reducing Medications to Sex Offenders:
Treatment or Punishment" (1998) Psychol Public Policy Law 175 at 178.
30. Scott & Holmberg, supranote 27.
31. Harry Sharp, "Vasectomy as a Means of Preventing Procreation in Defectives" (1909) 23 Jour
AMA 1897 at 1907.
32. Surgical castration of sex offenders is practiced in the Czech Republic. See Dan Bilefsky,
"Europeans Debate Castration of Sex Offenders" The New York Times (II March 2009), online:
<http://www.nytimes.com/2009/03/11/world/europe/ 11castrate.html>.
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under legislation in some American states," the surgical castration of sex
offenders has largely been replaced by chemical castration since the rise of
modem hormonotherapy during the 1940s.34
The use of drugs to lower male testosterone levels began in the first
half of the twentieth century. The novel ability to manipulate sex hormones
using drugs quickly morphed into a putative treatment for pathological
sexual behaviours. For example, by 1944, the first report on the use of
a hormonal medication (diethylstilbestrol) as a method for reducing
pathological sexual behaviour (i.e., sexual psychopathy and chronic
masturbation) appeared in the North American medical literature." In
1958, a physician at Johns Hopkins University, Dr. John Money, became
the first to report the successful treatment of nonparaphilic hypersexuality
and sex offenders using the drug MPA.36
During the 1970s, the first clinical studies of CPA as a treatment for
pathological sexual behaviour appeared in Germany.17 In 1985, LHRH
agonists were proposed as potential therapeutic agents in the treatment
of pathological sexual behaviour," and clinical studies of their use in this
capacity appeared in the medical literature during the early 1990s.19
Today, chemical castration of sex offenders is practiced in North
America, Britain, Europe and parts of Asia, but the practice is not
universally compulsory. 40 However, each jurisdiction has ostensibly
adopted the practice of chemical castration based on the view that it is a
rational medical treatment grounded in the modem scientific understanding
of the human brain and behaviour.4 '
III. Chemical castration: a scientific perspective
The scientific model underlying the use of chemical castration as a treatment
for sex offenders is based in complex biology but it can be reduced to
the simple idea that testosterone is critical for the maintenance of male
sexual behaviour. Evidence for this idea was originally obtained in animal
33. See Fred S Berlin, "Sex Offender Treatment and Legislation" (2003) 31 JAAPL510.
34. Scott & Holmberg, supra note 27 at 502.
35. Robert M Foote, "Diethylstilbestrol in the Management of Psychopathological States in Males"
(1944) J Nerv Ment Dis 928.
36. Codispoti, supra note 20 at 672.
37. Bradford, supra note 28 at 31.
38. Bradford, supra note 20.
39. Bradford, supra note 28 at 32.
40. See e.g. Alex Duval Smith, "France introduces chemical castration for sex offenders" The
Independent (Il November 2004), online: <http://www.independent.co.uk/news/world/europe/franceintroduces-chemical-castration-for-sex-offenders-532792.html>. See also Karen Harrison, "Legal
and Ethical issues when using Antiandrogenic Pharmacotherapy with Sex Offenders" (2008) 3 Sex
Offender Treatment I at 2.
41. See e.g. Bradford, supra note 28.
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studies 42 but has since accumulated from human studies evaluating the
effects of androgen replacement therapy in hypogonadal and eugonadal

men.43
Results from these studies have shown that reductions in sexual interest
and arousability occur after three to four weeks of testosterone withdrawal
and that normal levels of sexual interest and arousability can be restored with
testosterone administration.4 They show also that masturbation frequency
and erectile rigidity and duration appear closely tied to testosterone
levels. On this evidence, there appears to be a reasonably sound scientific
rationale to support the use of androgen deprivation treatment as a method
for suppressing the sexual urges of sex offenders. Interestingly, however,
the human studies have also shown that testosterone withdrawal does not
impair the ability to achieve penile erection, nor does it necessarily lead to
a reduction in the amount of sexual activity engaged in with partners. 45
IV. Chemicalcastrationand the Canadianlegal system: the dangerous
offender and long-term offender regime
In Part XXIV of the Criminal Code,4 6 Canadian law recognizes the need
for a special sentencing regime applicable to offenders who present a
uniquely high risk of recidivism. The primary objective of the dangerous
offender and long-term offender regime found there is "to protect the public
from offenders who have committed serious sexual or violent offences
(except murder) and continue to pose a threat to society." 41 In practice,
statistics indicate that in eighty per cent of dangerous offender hearings
the underlying offence was of a sexual nature,4 8 so the regime is applied
primarily to sex offenders.
1. The process
The Crown can make a dangerous offender application during the period
between conviction and sentencing.49 Consent of the attorney general of

42. Foote, supra note 35.
43. Hypogonadal men have low levels of testosterone due to inadequate secretion of
gonadotrophins.
44. John Bancroft, "The endocrinology of sexual arousal" (2005) 186 J Endocrinol 411.
45. Ibid at 413. Moreover, it is important to note here that sexual offending is not limited by the
ability to achieve an erection because sexual offences can encompass activities apart from forced
sexual intercourse.
46. CriminalCode, RSC 1985, c C-46, ss 752-61 [Code].
47. Parliamentary Information and Research Service, The Dangerous Offender and Long-Term
Offender Regime (Ottawa: Library of Parliament, 2008) at 1.
48. See Public Safety and Emergency Preparedness Canada, Correctionsand ConditionalRelease
StatisticalOverview, December 2007 at 103-105. Cited in: ibid at 1.
49. Supra note 46 at s 753(2) gives the Crown an additional six months to make the application
should new evidence arise.
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the province within which the application is being made is required before
the application can proceed. In addition, offenders must be given notice of
the hearing at least one week before its scheduled date and the notice must
contain the basis for the Crown's application. 0
Under s. 752.1(1) of the Code, the Court (where it has reasonable
grounds to believe that the offender may be found to be a dangerous
offender under s. 753 or long-term offender under s. .753.1) must order
the offender remanded for a sixty-day dangerousness assessment to be
completed by a multidisciplinary team of experts in corrections and mental
health. The purpose of the assessment is to determine the extent of the risk
the offender represents to the public and whether there is a reasonable
possibility of eventual control of that risk in the community."'
2. The hearing
Dangerous and long-term offender . hearings proceed under relaxed
evidentiary rules that allow for the admission of evidence concerning
the offender's morality, reputation, prior convictions and previous bad
behaviour (not resulting in charges).5 2 The core evidentiary component of
dangerous and long-term offender hearings comprises expert reports and
testimony.
The Code, in s. 753(1), sets out the requirements for a dangerous
offender designation. The Crown must prove beyond a reasonable doubt
that the offender has committed a 'serious personal offence' and that he
or she represents a danger to society because of the likelihood of causing
significant harm by reoffending."
Under s. 754(5), if the dangerous offender requirements are not met,
the Court can treat the application as for long-term offender status. In such
cases, the Court will consider whether the offender meets the statutory
criteria for that status under s. 753.1(1) of the Code.
50. Code, supra note 46 at s 754(1)(a) and (b).
51. This court-ordered assessment is intended to provide a neutral set of expert opinions for the
court to consider during the hearing. The adversarial battle of the experts under the old DO regime
is therefore largely done away with, however, although not expressly granted under the Code parties
retain the option to supplement the court ordered assessment with additional expert opinion on
condition that the court finds the evidence relevant. See David MacAlister, "Use of Risk Assessments
by Canadian Judges in the Determination of Dangerous and Long-Term Offender Status, 1997-2002"
in Law Commission of Canada Law and Risk (BC Canada: UBC Press, 2005) at 36. Readers who
are interested more broadly in the content of the court ordered assessments are referred to: Bloom &
Schneider supra note 26 at 249-56.
52. Regarding the admissibility of evidence concerning the offender's morality or reputation, see
Code at s 757. Regarding the admissibility of evidence concerning evidence of behaviour that did not
result in criminal charges, see Rv Neve, 1999 ABCA 206, 137 CCC (3d) 97.
53. See generally Kirk Heilbrun, James RP Ogloff & Kim Picarello, "Dangerous Offender Statutes
in the United States and Canada" (1999) 22 Int J Law Psychiatry 393.
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As a result, dangerous offender applications generally proceed with
the Crown arguing that an offender should be declared a dangerous
offender and the defence arguing in favour of long-term offender status.
It is an understatement to call the difference between the two designations
significant. In practical terms (given that only approximately five per cent
of dangerous offenders are ever released from prison whereas long-term
offenders are given supervised release following a determinate sentence5 4),
the difference can be whether the offender will ever see the outside of a
correctional institution.
The judge has considerable discretion in determining whether to
designate an offender as either a dangerous or a long-term offender. At its
core, the decision rests on whether the judge is satisfied, based on his or
her assessment of the expert evidence, that there is a reasonable possibility
of eventual control of risk in the community. At the hearing, neither side
has the onus of convincing the judge on this matter and neither the criminal
nor civil standard of proof applies. 5 Rather, the law in this area holds that
in determining whether a reasonable possibility of control of the offender's
risk in the community exists, the "mere wishing or speculating that he [the
offender] will want to succeed, and will succeed, in controlling that risk is
insufficient" 6 and that, "[t]here must be evidence oftreatability that is more
than an expression of hope and that indicates that the specific offender can
be treated within a definite period of time."57 The judge therefore considers
all the evidence and decides whether it is strong enough to satisfy him
or her that the offender can, with appropriate treatment, be controlled in
the community. The critical nature of the expert evidence on this subject
is obvious and in many cases judges are left to side with one of several
potentially conflicting expert opinions.
A review of dangerous and long-term offender hearings involving
chronically recidivist pedophiles makes it quickly apparent that judges'
decisions as to whether there exists a reasonable possibility of controlling
the offenders' risk in the community is often influenced by expert testimony
on the subject of chemical castration. Consider the following examples
from recent cases:
None of this suggests that Mr. Maxwell presents a reasonable possibility
54. Public Safety Canada reports that as of July 2006, there were 351 active offenders with the
Dangerous Offender designation, and of these only 18 had received parole while the other 333
remained incarcerated. Online: < http://www.publicsafety.gc.ca/prg/cor/tls/dod-eng.aspx>.
55. See R vFED, 2007 ONCA 246 at para 50, 84 OR (3d) 721. The law in this area is also helpfully
reviewed in Maxwell, supra note 12 at paras 25-33.
56. Ibidatpara3O.
57. Ibid.
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of eventual control of the risk in the community. With his history of
deceit, I just do not trust him to do what he must. I must agree with
Dr.Woodside that he only presents as a hope of control. With his history
of letting his sexual interest in pubescent boys find expression, and
especially if he fails to take or continue taking anti-androgen drugs, I
would expect he will offend again."
I am not convinced that the offender's sexual deviancy can be controlled
because all five recommendations of Dr Woods must be followed,
including and especially the prescription of an effective anti-androgen
drug, such as Androcur, in sufficient doses. However, if the five
requirements set out by Dr Woods are completely followed during the
duration of the long-term offender supervision period, then there is a
reasonable possibility of eventual control of the offender's risk in the
community. 9
In my opinion, he is unlikely to take the anti-androgen drugs in the
future, and in any event, because of his overall attitude, he is unlikely
to benefit from them even if he took them. Dr. Woodside's view, which
I share, is that without this particular form of drug therapy, the risk of
Mr. Clancy reoffending is extreme and not reasonably manageable in
the community.60
Bearing in mind the nature of the offences committed by Mr. Smith and
the role that substance abuse has played in his offending behaviour, as
well as the expert evidence regarding the effectiveness of Antabuse and
antiandrogen drugs in lowering risk, it seems more than probable that
these drugs would be recommended by Mr. Smith's treating psychiatrist.
Certainly both Dr. Gojer and Dr. Klassen would recommend their use
in this case. A treatment plan incorporating the taking of Antabuse and
antiandrogendrugs - a plan that Mr. Smith would have to follow or be
charged with a breach of the long-term supervision order - would be
an effective way of keeping Mr. Smith's risk of re-offence at a low or
6
acceptable level. '
In myview, it is crucial that Mr. Stoney take medicine under the direction
of a psychiatrist and participate in therapy while on parole supervision.
The offender cannot be given an option as to these conditions. Antiandrogen drugs may have unpleasant side effects. Mr. Stoney has
shown a propensity to avoid participation in programs of which he does
not approve. This cannot be an option for him related to drug treatment.
If his participation is dependent upon his continued agreement, then
that agreement may change. This would defeat the management of Mr.
Stoney within the community.62

58.
59.
60.
61.
62.

Supra note 12 at para 127.
Ibid at para 103.
R v Clancy (2007), 74 WCB (2d) 655, [2007] OJ no 3145 at para 109 (Sup Ct J).
Smith, supra note 12 at para 148.
Stoney, supranote 12 at para 131.
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V. The legal imposition of chemical castration:understandingthe
process
In order to explore the ethical dimensions of forced chemical castration
under Canadian law, it is important to establish how this treatment can be
imposed. Typically, the process of forcing an offender to be chemically
castrated begins at the conclusion of sentencing, after the judge has decided
to make a long-term offender designation. 63 In view of the offender
eventually returning to the community under a long-term supervision
order, the trial judge provides a set of conditions he or she believes ought
to attach to the offender's supervision order. These recommendations are
provided for the benefit of the National Parole Board (NPB), and although
they are not binding on the NPB, it is unlikely they would be issued if
judges were not confident that they would be followed. An example of
such judicial recommendations is in R. v. Stoney, where having found
Mr. Stoney to be a long-term offender, Allan PCJ made the following
recommendations:
I realize that the NPB will decide what conditions that are part of Mr.
Stoney's supervision order at the time of his release from custody.
However, I will make the following recommendations for consideration
of the NPB:
* When released in the community, Mr. Stoney should live in a
controlled residential facility.
* The parole officer should make random checks related to his place of
residence.
* It would be beneficial to Mr. Stoney to have support systems. Mr.
Stoney should be ordered to cooperate with community programs
such as "Circles of Support". This will assist Mr. Stoney while in the
community.
63. It is possible that legally mandated chemical castration is occurring in another context that makes
the process more common than is apparent in reported dangerous offender cases: plea agreements.
Statistics showing the proportion of felony convictions obtained by guilty plea (95 per cent) cited by
one US author (John Stinneford, 'Incapacitation Through Maiming: Chemical Castration, The Eighth
AmendmentAnd The Denial Of Human Dignity'(2005) 3 U St Thomas LJ 559 at 563) formed the basis
for the conclusion that the majority of offenders chemically castrated in the US receive the treatment
pursuant to the terms of their plea bargain agreements (see Debra Wilson, The Legal Implications of
Chemical Castration ofSex Offenders in Criminal Law, in Michael Adams, David Barker & Katherine
Poludniewski, eds, Australasian Law Teachers Association -ALTA, 2007 Refereed Conference Papers
(Perth, Western Australia: 2007) at 13). Canadian data indicate that over 90 per cent of criminal cases
are resolved without trial (see Department of Justice Canada, Plea Bargaining by Milica Potrebic
Piccinato (Ottawa: Department of Justice Canada, 2004) at 6) and this suggests that there is ample
opportunity for the legal imposition of chemical castration outside the dangerous and long-term
offender regime. This is potentially problematic and requires further study.
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* Upon his release, he should participate in continued therapy for sex
offenders.
* He should be required to take anti-androgen medication or other
medication to control sexual fantasies ds prescribed by a treating
physician.

* He should abstain absolutely from alcohol, solvents, narcotics, or
other intoxicating substances. He is only to take medication pursuant
to a medical prescription.
* In addition, he should be required to be subject to random testing to
ensure compliance with the abstinence condition.6
These judicial recommendations represent only the beginning of the
story because the legal power to impose medical treatment on long-term
offenders ultimately lies with the NPB. The leading case in this area is
Deacon v. Canada(Attorney General)."

Deacon concerned an appeal to the Federal Court of Appeal from a
National Parole Board (NPB) decision refusing to remove a condition from
the long-term supervision order of convicted pedophile Shaun Deacon.
The condition forced Mr. Deacon to "take medication as prescribed- by a
physician" (including the anti-androgen medication Lupron to suppress
sexual appetite and control sexual fantasies). 6 6 Mr. Deacon argued that
this condition violated his s. 7 Charter right to not be deprived of life,
liberty or security of the person except in accordance with the principles of
fundamental justice. In ruling there was no violation, the Federal Court of
Appeal discussed the process and the legal basis for imposing compulsory
medical treatment as part of an offender's long-term supervision order.
The Court described how upon expiration of the offender's warrant
of committal he becomes subject to the statutory jurisdiction of the NPB.
The Court then explained that the NPB's statutory jurisdiction to impose
conditions on a long-term offender derived from s. 753.2(1) of the Code and
s. 134.1(2) of the Correctionsand ConditionalRelease Act 7 as follows:
753.2(1) Subject to subsection (2), an offender who is required to be

64. Stoney, supranote 12 at para 229.
65. Deaconv Canada(Attorney General), 2006 FCA265, [2007] 2 FCR 607, leave to appeal to SCC
ref'd, 31596 (11 January 2007).
66. In addition to Lupron, Shaun Deacon was also required, as part of his LTSO, to take the
following medications: the anticonvulsant drug Topiramate to treat post-traumatic stress disorder; the
antidepressant drug Zoloft to treat anxiety disorder and lower libido; the cholesterol-lowering drug
Lipitor and progesterone to treat side effects of the other medications; and Turns calcium tablets and
multivitamins, also to help alleviate side effects of the other medications.
67. Corrections and ConditionalRelease Act, SC 1992, c 20 [CCRA].
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supervised by an order made under paragraph 753.1(3)(b) [long term
supervision order] shall be supervised in accordance with the Corrections
and ConditionalRelease Act when the offender has finished serving
(a) the sentence for the offence for which the offender has been
convicted; and
(b) all other sentences for offences for which the offender is
convicted and for which sentence of a term of imprisonment is
imposed on the offender, either before or after the conviction for
the offence referred to in paragraph (a).
134.1(2) The Board may establish conditions for the long-term
supervision of the offender that it considers reasonable and necessary in
order to protect society and to facilitate the successful reintegration into
society of the offender
The Federal Court of Appeal interpreted s. 134.1(2) of the CCRA using
a broad and purposive approach that began with an exposition of the
purpose of the statutory regime for long-term offenders. Writing for the
Court, Linden J.A. made the following observations:
An offender whose conduct or behaviour is not "pathologically
intractable", in that there is a reasonable possibility that the offender can
eventually reach a stage where, although not curable, his or her risk can
be controlled in the community, will now qualify for long-term offender
status. Under the former provisions, such an offender-for example,
a repeat sexual offender-might have been found -to be a dangerous
offender. Long-term supervision orders thus pursue two main objects:
first, protecting society, and second, enhancing the social reintegration
of long-term offenders, wherever possible, by granting release under the
least restrictive conditions consistent with the protection of society."
The Court noted the absence of any express CCRA provision granting
the NPB authority to order forced medical treatment; however, it concluded
that:
If the statutory purposes of protecting society and enabling social
reintegration of long-term offenders through supervised release with the
least restrictive conditions possible are to be achieved, the Board must
possess the power to impose a medical treatment condition in appropriate
circumstances. 69
Having decided that the NPB was empowered to impose a condition

for forced medical treatment, the Court-foreshadowing its position on
the Charterargument-suggested that the NPB did not force Mr. Deacon
68.
69.

Deacon, supranote 65 at para 36.
Ibidatpara 38.
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to take the medication. Mr. Deacon, the Court opined, remained "at liberty
to refuse to take the prescribed medication." 0 But, they continued, "if
he does, there will be consequences for such a refusal: the appellant will
be in breach of his long-term supervision order and therefore liable to
commitment under section 135.1 of the CCRA or imprisonment pursuant
to section 753.3 of the Criminal Code."7 The option for Mr. Deacon was
to take the drugs or go back to jail. This was an unpalatable option to be
sure, but the Court was right in noting that Mr. Deacon did have some
choice as to whether he would receive the medication.
On the Charterarguments, the Court agreed that the condition requiring
Mr. Deacon to take medication was a violation of his rights to liberty and
security of the person. 72 Nevertheless, the Court ruled that this violation
was consistent with the principles of fundamental justice. First, the Court
held that the requirement of express legislative authorization for forced
medical treatment was not a principle of fundamental justice. Second,
the Court held that the right to refuse unwanted medical treatment was not
an absolute unqualified right and could not therefore be elevated to the
status of a principle of fundamental justice:
Contrary to the appellant's assertion, I do not think the requisite broad
societal consensus is present concerning an absolute right to refuse
unwanted medical treatment in every situation for the latter to be
recognized as a principle of fundamental justice. Rather, the right to
refuse medical treatment, while perhaps accepted as a general rule, is
74
also recognized as properly subject to limitations in certain contexts.

Based on its analysis, the Court unanimously upheld the condition of Mr.
Deacon's long-term supervision order and with it the constitutionality of
the legal regime empowering the NPB to impose conditions of release that
require a long-term offender to choose between chemical castration and
prison.
VI. Chemical castrationto prevent recidivism in sex offenders: assessing
the evidence
In reviewing the medical evidence for the efficacy of chemical castration,
two topics warrant preliminary discussion. The first is the high human
cost of prognostic uncertainty, and the second concerns a set of issues that
complicate studies of sex offender treatments.
70.
71.
72.
73.
74.

Deacon,supranote 65 at para 40.
Ibid
Ibidat para 49.
Ibidat para 56.
Ibidat para 71.
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1. Prognosticuncertainty
For conventional medical treatments, where the purpose is to help the
individual who suffers from a particular illness or disease, a preventative
drug therapy that works in six out of ten patients would generally be
considered successful." Consider that the number needed to treat (a
statistical measurement based on absolute risk that tells us how many people
need to receive a drug in order to prevent one incident) 6 for atorvastatin
(Lipitor) and other cholesterol lowering statins is 16-23 to prevent one
heart attack in populations that show signs of heart disease, and 70-250 to
prevent one heart attack in populations with risk factors for, but no signs
of heart disease. This means that, in a population suffering from heart
disease, Lipitor will prevent one heart attack for every 16 people who take
the medication.
In the case of chemical castration (when imposed as a parole condition),
the pharmacotherapy is unconventional because its primary purpose is
to prevent harm to society rather than to the recipient. It follows that an
assessment of this treatment's efficacy should differ from assessments
of conventional treatments. The failure of chemical castration to achieve
remission of sexual deviancy likely entails the commission of a sex crime.
Accordingly, the level of success demanded (i.e., the threshold used for
determining efficacy) from such a treatment should arguably be much
higher than is required of conventional preventative pharmacotherapies.
This level of prognostic certainty is currently not possible for chemical
castration. At the very least, courts should attempt to take into account
what level of uncertainty society is prepared to accept when considering
the release of recidivist sex offenders treated using sex-drive-reducing
medications:
2. Sex-offender research:the challenges
The second preliminary issue concerns problems with sex offender
research relating to assessment, study design, sampling and follow-up."
75. It is important to note that in assessing the potential utility of a medical treatment one single
metric, such as the NNT, is not a sufficient basis on which to form a reasoned and thorough clinical
opinion as to whether that treatment should be used in certain circumstances. Additional knowledge is
required to inform clinical judgement, including, for example, knowledge of the treatment's potential
side effects and the natural course of the disease/illness that is the target of treatment.
76. Lonnie Wen, Robert Badgett & John Cornell, "Number needed to treat: a descriptor for weighing
therapeutic options" (2005) 62 Am J Health Syst Pharm 2031.
77. See Therapeutics Initiative, Business Week (31 May 2010), online: < http://bpO.blogger.com/
ZiPiXEv Q_g/R5DjN-M3c71/AAAAAAAABAc/toNCnOZ3Jo/sl600-h/BusWeek-NNT-Table.
gif>.
78. Linda S Grossman, Brian Martis & Christopher G Fichtner, "Are Sex Offenders Treatable? A
Research Overview" (1999) 50 Psych Serv 349.
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Investigators face problems in assessment because there are no agreedupon standardized measurement techniques that can reliably and validly
measure the frequency of sex offences. They face problems with study
design because of reluctance to randomize sex offenders to control groups,
in part because of an erroneous belief that it would be unethical not to
provide control groups with treatment." They face problems with sampling
because the heterogeneity and small size of the sex offender population
makes it difficult to control potential clinically relevant variables (e.g.,
socioeconomic status, age, type of offence, etc.) within a study population.
Finally, investigators face problems with measuring recidivism because of
the long duration of the necessary follow-up periods (it has been suggested
that to properly assess recidivism offenders have to be followed for at
least five to seven years after treatment). These challenges have limited the
reliability and validity of sex offender research and should be addressed.
VII. Evidencefor the use of chemical castrationto prevent recidivism
Statements supporting the use of chemical castration in the treatment of
sex offenders are not uncommon in the medical literature. For example,
a recent editorial in the British Medical Journal contained the following
claim: "Antiandrogenic drugs and physical castration undoubtedly reduce
sexual interest (libido) and sexual performance, and they reduce sexual
offending.""o Nevertheless, such assertions ignore the lack of a sufficiently
reliable evidentiary basis for the efficacy of these treatments.
The effectiveness of sex offender treatment has been studied and
reviewed fairly extensively over the past ten years." In assessing the
results, some authors have suggested that sex offender treatments are
useful, on balance, because of figures purportedly showing that treated
participants have absolute recidivism rates that are six and a half per cent
to eight per cent lower than untreated participants.82 Other authors have

79. This is an erroneous view for at least two reasons. First, it ignores the fact that the available
treatment has not been proven effective and cannot therefore be considered an established treatment.
Second, it ignores the fact that all other parole and treatment conditions would have to be consistent
and therefore that those offenders in the control group would still be receiving non-pharmacological
treatment alongside offenders in the treatment group and both groups would still be subject to other
restrictive parole conditions.
80. Editors, "Chemical Castration for Sex Offenders" (2010) 340 BMJ c 74.
81. See generally Leigh Harkins & Anthony Beech, "Measurement of the effectiveness of sex
offender treatment" (2007) 12 Aggress Violent Behav 36.
82. See Dennis M Doren & Pamela M Yates, "Effectiveness of Sex Offender Treatment for
Psychopathic Sex Offenders" (2008) 52 Int J Offender Ther Comp Criminol 234; see also Friedrich
Lsel & Martin Schmucker, "The effectiveness of treatment for sexual offenders: A comprehensive
meta-analysis" (2005) 1 J Exp Criminol 117.
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expressed concerns about design problems with the studies on which such
positive assessments are based."
In light of the ongoing debate in the medical literature, it would be
prudent to conclude that the efficacy of sex offender treatments has yet
to be conclusively established. Moreover, there has been insufficient
consideration in the literature of harm related to prognostic uncertainty and
therefore even if treatments reduce recidivism at statistically significant
levels, this finding may not provide sufficient evidence to support their use
in highly dangerous populations.
Given the risks associated with treatment failure in populations of
recidivist sex offenders it seems reasonable to demand that evidence
for treatment efficacy be derived only from studies employing the
most scientifically rigorous methodology. Fortunately, the Cochrane
Collaboration recently published a review on the topic of management
for people with disorders of sexual preference and for convicted sexual
offenders.8 4 This review specifically assessed the existing evidence for the
efficacy of pharmacotherapy (i.e., chemical castration) in sex offenders.
The Cochrane Collaboration produces what is widely considered to
be the gold-standard review of the existing clinical evidence for medical
treatments because the reviewers apply strict methodological criteria
in selecting studies for review. These criteria lead to the exclusion of
research studies that do not use randomized controlled designs to avoid
the introduction of error and bias into conclusions concerning clinical
efficacy.
Assessing the whole of the sex offender literature, the Cochrane
Collaboration was able to identify only a single study using anti-androgen
medication that met their inclusion criteria. After reviewing the study,
the authors provided the following advice for physicians: "anti-libidinal
drugs should be used with caution [because] there is no trial-derived data
to support or refute their use."" They then suggested that use of such
medication should be considered experimental and that its use could only
be justified in the context of well-conducted randomized experimental
trials.16
The Cochrane Collaboration reveals the negligible evidentiary base for
the use of chemical castration to prevent recidivism in sex offenders. This
is troubling in light of case law that reveals Canadian courts are relying
83. Doren & Yates, supra note 82 at 235.
84. Paul White et al, "Management for people with disorders of sexual preference and for convicted
sexual offenders (Review)" (2009) The Cochrane Library 1.
85. Ibidat 9.
86. Ibid.
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on expert testimony in support of chemical castration when deciding to
grant recidivist sex offenders long-term offender status, thus ensuring the
offenders will return to our communities.
VIII. Chemical castrationin Canadiancaselaw
Since 1997, when the Criminal Code was amended to include the longterm offender designation," there have been at least fifteen reported cases
of dangerous or long-term offender hearings that considered the possibility
of legally mandating chemical castration for recidivist pedophiles. In eight
cases, the court opted for the dangerous offender designation, while longterm offender status was granted in the other seven."
A review of these cases makes it clear that expert opinion on whether
chemical castration will provide an effective means for preventing
recidivism is often central to the decision as to which designation the
offender ultimately receives. This judicial focus on chemical castration
continues in spite of the fact that both the British Columbia Court of
Appeal" and the Ontario Court of Appealo have openly criticized the use
of chemical castration because of doubts concerning its utility. Given the
limited clinical evidence supporting its use in the sex offender population,
it is troubling, to say the least, that this treatment continues to hold sway
on judicial decision-making. As the following section illustrates, chemical
castration of sex offenders also raises troubling ethical issues that call
Canadian practice into question.
IX. Ethical issues surroundinglegally mandatedchemical castration
1. Validity of consent
It is well-established law in Canada that no competent person shall receive
medical treatment unless they have given their voluntary and informed
consent." Similarly, the Canadian Medical Association Code of Ethics

87. Supra note 11.
88. Supra note 12.
89. JSM, supra note 12. This case overturned a lower court decision granting JM long-term
offender status (R v JSM, 2001 BCSC 763, 50 WCB (2d) 522) because the trial judge's reliance on
JM's assurances that he would submit to chemical castration was held to amount to an error of law.
However, in an interesting twist, the case was sent back to the trial level, and JM was eventually given
the long-term offender status based largely on the trial judge's acceptance of the utility of chemical
castration (see Rv JSM, 2003 BCSC 1813, 60 WCB (2d) 202).
90. Although the case in the Ontario Court of Appeal was heard prior to the introduction of the
long-term offender regime, Austin JA strongly disapproved of the evidence in support of the utility
of chemical castration as a means for preventing recidivism, see Stuckless, supranote 17 at paras 8182.
91. Peppin, supra note 2.
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requires that physicians respect the right of a competent patient to accept
or reject recommended medical care.92
In the context of treatment administered under conditions attached to
long-term supervision orders, it is questionable whether the patient/offender
is capable of giving legally- and ethically-adequate consent. The reason for
this is straightforward. The patient/offender is placed in a situation where
they must choose between remaining in prison, perhaps indefinitely, and
receiving the treatment. Accordingly, any decision by the patient/offender
to consent to the treatment may lack the requisite level of freedom for
valid consent to be given. Longstanding legal and ethical doctrine holds
that consent cannot be voluntary if it is given by a patient who is coerced
or under duress." Notwithstanding the decision of the Federal Court of
Appeal in Deacon, the consent that can be achieved under such catch-22
conditions (i.e., jail versus medication) is inconsistent with that doctrine.
In fact, even accepting that the consent in this situation is legally valid,
it remains firmly inconsistent with ethical principles governing medical
treatment. Thus, physicians who participate in legally mandated chemical
castration would be acting outside the ethical norms of their profession.
It may be that in dilemmas like those presented by repeat sex offenders
the legal and ethical rules governing consent should be relaxed. Mandating
the chemical castration of repeat sex offenders might seem justifiable if the
alternative is keeping the offender in prison, perhaps indefinitely (if the
treatment is ever proved efficacious). In Deacon, however, that argument
was not made. Rather, the practice was constructed to 'fit' within existing
legal doctrine through the Court's suggestion that Mr. Deacon was able to
give valid consent because he did, after all, have a choice. Constructing
the law to fit the practice is ethically troubling.
2. Criminalacts or manifestations of illness?
A second ethical issue, which might be called the inconsistency problem,
arises where the release of an offender is predicated on his acceptance
of receiving medical treatment to control a pathological condition. The
inconsistency problem exists because two competing and fundamentally
inconsistent conceptualizations of the underlying problem are
simultaneously at play with the offender/patient caught in the middle.
Consider that the offender is assumed to have committed a criminal
act that is morally repugnant and born of his own free will; the minimum
justification for penal sanctions is therefore met. At the same time,
92. Canadian Medical Association, Code of Ethics, online: <http://www.cma.ca/index.cfm?ci
id-46137&laid=1 &requiredfields=&q=code+of+ethics&x=O&y-O&proxycustom=> #24.
93. Peppin, supra note 2 at 191.
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however, the offender is told that his pathological behaviour is amenable
to hormone-reduction therapy and that he must receive medical treatment
to help assuage his criminal impulses. Implicit in this is the suggestion
that his criminality is traceable to biology and not acts born of free will.
Thus arises the inconsistency problem.
The offender is caught between two conceptual worlds, and subjected
to the worst of both. To resolve this ethical dilemma it appears that we
should either (1) decide that recidivist sex offenders are criminals who
freely choose to act and punish them with criminal sanction alone; or (2)
decide that recidivist sex offenders suffer from an illness and treat them
medically, perhaps following the civil committal model. Instead, Canadian
law has adopted both conceptions and this is ethically, if not legally,
problematic.
Clearly, any argument suggesting that criminals should not be offered
behavioural modification therapy (either through psychotherapy or
pharmacotherapy, or both) would be inconsistent with years of practice.
Further, there may actually exist a clear responsibility, if we subscribe to
the rehabilitative model of criminal sanctions, to offer treatment.
It is important to recognize that the inconsistency issue described
above does not question whether treatment should be made availableif an effective treatment exists it would seem unethical not to offer itbut rather the fact that treatment aimed at alleviating a crime-inducing
pathology is forced upon an individual supposedly being criminally
punished for acting of his own free will. A possible solution is to recognize
the use of chemical castration as preventive supervision as opposed to
medical treatment. Unfortunately, as discussed in the following subsection,
physician participation in such a practice could be unethical.
3. Treatment or punishment? Physicians as agents ofsocial control
It may be inaccurate to cast the administration of sex-drive reducing drugs
as a medical treatment for certain types of sexual disorders. In the case of
a recidivist pedophile for example, the problematic characteristic is not
that the pedophile's sex drive is overactive, but rather that it is misdirected
(i.e., at children rather than adults). Chemical castration does nothing
to alter that misdirection and therefore does not target the underlying
pathology that motivates the pedophile to offend. Additionally, the drugs
can cause serious and potentially life-threatening side effects, including
depression, osteoporosis, thromboembolism and stroke. 94 Therefore, it

94. Erik J Giltay & Louis JG Gooren, "Potential Side Effects of Androgen Deprivation Treatment in
Sex Offenders" (2009) 37 JAAPL 53.
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may be ethically problematic to accept the view that chemical castration
is a medical treatment. It may be better conceived of as an extension of
criminal sanctions-as a punishment-whereby the long arm of the law
reaches into the community.
The American Medical Association (AMA) has released an opinion
paper on court-initiated medical treatments in criminal cases that addressed
the treatment versus punishment issue. The AMA concluded that, "in order
to consider a particular court-initiated treatment a treatment and not a
punishment, it would have to effectively treat the disorder that motivates
the patient to offend." 5 The AMA also held that physicians should not
participate in court-ordered punishments which might make them agents
of social control. 9 6 Given that the chemical castration of pedophiles does
nothing to address the offender's misdirected sexual desires, the AMA
position seems to preclude physician participation in court-ordered
chemical castration of recidivist pedophiles.
In Canada, the arguments in the AMA position paper may not be quite
as persuasive because under Canadian law neither the Court nor the NPB
directly orders the chemical castration of repeat sex offenders. Rather, the
NPB simply requires, as part of its conditional release, that the "offender
take all medications as prescribed by a physician." However, whether this
changes the assessment of physician participation is arguably unimportant,
because regardless of whether the castration was ordered on the advice
of a physician or by a court (and in Canada it is effectively ordered by
both), it fails to treat the underlying pathology and therefore should not be
properly conceived of as therapy.
To summarize, physician participation in chemical castration seems
precluded for two reasons: first, because chemical castration is not a
treatment, but rather a form of social control and, second, on the basis that
providing the treatment falls outside the ethical norms of the profession
with regard to the requirements for voluntary and informed patient
consent.
Conclusion
This paper suggests that when implemented under the coercive power of
law, the chemical castration of repeat sex offenders is inconsistent with
established canons of medical ethics and poorly supported by clinical
evidence. It follows that the employment of chemical castration in the
95. American Medical Association, Opinion 2.065 - Court Initiated Medical Treatment in Criminal
Cases (31 May 2010), online: <http://www.ama-assn.org/ama/pub/physician-resources/medicalethics/code-medical-ethics/opinion2065.shtml>.
96. Ibid.
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Canadian legal system represents a misguided, almost faith-based, use
of an unproved and potentially dangerous medical treatment as a risk
management tool. The use of this so-called treatment not only puts
physicians and their patients in ethically troubling positions, but may also
engender a sense of false security among judges and the general public
concerning the likelihood that sex offenders will re-offend. Ultimately,
any reliance on this practice in our criminal justice system as grounds
for releasing recidivist pedophiles into our communities represents a clear
threat to children and other potential victims of sexual predators.
It is possible that the use of anti-androgen medications may one day
have an effective role in the Canadian justice system. However, at present,
the clinical evidence does not support the use of chemical castration in
criminal law. Should the day come when it does, other issues including the
use of medication as a form of social control will remain to be confronted
before chemical castration can be accepted as an ethical and socially
acceptable component of the Canadian justice system.
For the time being, given how few options exist for managing
recidivist sex offenders, it is seems unlikely that chemical castration will
disappear from the Canadian legal landscape. Accordingly, judges should
be mindful of the problems associated with it and avoid being swayed.
by impressively-credentialed witnesses and evocative language when they
make decisions concerning whether chronically recidivist sex offenders
should be eligible for conditional release.

